Strides Pharma Scien Latest News

  1. Strides Pharma Science has informed that it has attached Press Release on 15th January 2021, titled ‘Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets’.

    Date:15-01-2021
  2. The company has 127 cumulative ANDA filings with USFDA of which 95 ANDAs have been approved and 32 are pending approval
    Date:15-01-2021
  3. The company has 127 cumulative ANDA filings with USFDA of which 95 ANDAs have been approved and 32 are pending approval
    Date:15-01-2021
  4. Strides Pharma Science has informed that it has attached Press Release issued by the Company on 8th January 2021, titled ‘Aditya Puri joins as Advisor to the Strides Group & Director of Stelis Biopharma’.<...

    Date:08-01-2021
  5. Strides Pharma Science has informed that it has enclosed press release titled, ‘Strides receives USFDA approval for Oxybutynin Chloride Tablets’.
    Date:18-12-2020
  6. The product will be manufactured at the company’s flagship facility at Bengaluru
    Date:18-12-2020
  7. The product will be manufactured at the company’s flagship facility at Bengaluru
    Date:18-12-2020
  8. The product will be manufactured at the company’s flagship facility at Bengaluru
    Date:24-11-2020
  9. The product will be manufactured at the company’s flagship facility at Bengaluru
    Date:23-11-2020
  10. Strides Pharma Science has informed that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, October 29, 2020 to consider and approve the unaudited financial results (standalone and c...

    Date:23-10-2020
Return to Top
Puchho Befikar